Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View

Merck (MRK) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.72, which beat the Zacks Consensus Estimate of$1.69. In the year-ago period, management reported adjusted EPS of 3 cents. This significant upside was on account of a one-time charge incurred by the company in the year-ago quarter for a collaboration with Daiichi Sankyo.See the Zacks Earnings Calendar to stay ahead of market-making news.Revenues rose 7% year over year (9% excluding Fx) to $15.62 billion. Sales also beat the Zac ...